Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals

Mikko Koivumäki, Henna Martiskainen, Mari Takalo, Jenni Lehtisalo, Tiia Ngandu, Unknown, Anniina Snellman, Mikko Hiltunen, Juha O. Rinne

Open source

DOI
10.1186/s13195-026-01984-y
Published
2026-02-19
Container
Alzheimer's Research & Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13195-026-01984-y,
  title = {Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals},
  author = {Mikko Koivumäki and Henna Martiskainen and Mari Takalo and Jenni Lehtisalo and Tiia Ngandu and Unknown and Anniina Snellman and Mikko Hiltunen and Juha O. Rinne},
  year = {2026},
  journal = {Alzheimer's Research \& Therapy},
  doi = {10.1186/s13195-026-01984-y},
  url = {https://doi.org/10.1186/s13195-026-01984-y}
}

RIS

TY  - JOUR
TI  - Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals
AU  - Mikko Koivumäki
AU  - Henna Martiskainen
AU  - Mari Takalo
AU  - Jenni Lehtisalo
AU  - Tiia Ngandu
AU  - Unknown
AU  - Anniina Snellman
AU  - Mikko Hiltunen
AU  - Juha O. Rinne
PY  - 2026
JO  - Alzheimer's Research & Therapy
DO  - 10.1186/s13195-026-01984-y
UR  - https://doi.org/10.1186/s13195-026-01984-y
ER  - 

APA

Koivumäki, M., Martiskainen, H., Takalo, M., Lehtisalo, J., Ngandu, T., Unknown, Snellman, A., Hiltunen, M., & Rinne, J. O. (2026). Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-026-01984-y

Source records